<p>The aim of this study was to evaluate the benefit of a volumetric AI-based body composition analysis (BCA) algorithm in multiple myeloma (MM). Therefore, a retrospective monocentric cohort of 91 MM patients was analyzed. The BCA algorithm, powered by a convolutional neural network, quantified tissue compartments and bone density based on routine CT scans. Correlations between BCA data and demographic/clinical parameters were investigated. BCA-endotypes were identified and survival rates were compared between BCA-derived patient clusters. Patients with high-risk cytogenetics exhibited elevated cardiac marker index values. Across Revised-International Staging System (R-ISS) categories, BCA parameters did not show significant differences. However, both subcutaneous and total adipose tissue volumes were significantly lower in patients with progressive disease or death during follow-up compared to patients without progression. Cluster analysis revealed two distinct BCA-endotypes, with one group displaying significantly better survival. Furthermore, a combined model composed of clinical parameters and BCA data demonstrated a higher predictive capability for disease progression compared to models based solely on high-risk cytogenetics or R-ISS. These findings underscore the potential of BCA to improve patient stratification and refining prognostic models in MM.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

AI-based body composition analysis of CT data has the potential to predict disease course in patients with multiple myeloma

  • Franz Wegner,
  • Malte Maria Sieren,
  • Hanna Grasshoff,
  • Lennart Berkel,
  • Christoph Rowold,
  • Marcel Philipp Röttgerding,
  • Soleiman Khalil,
  • Sam Mogadas,
  • Felix Nensa,
  • René Hosch,
  • Gabriela Riemekasten,
  • Anna Franziska Hamm,
  • Nikolas von Bubnoff,
  • Jörg Barkhausen,
  • Roman Kloeckner,
  • Cyrus Khandanpour,
  • Theo Leitner

摘要

The aim of this study was to evaluate the benefit of a volumetric AI-based body composition analysis (BCA) algorithm in multiple myeloma (MM). Therefore, a retrospective monocentric cohort of 91 MM patients was analyzed. The BCA algorithm, powered by a convolutional neural network, quantified tissue compartments and bone density based on routine CT scans. Correlations between BCA data and demographic/clinical parameters were investigated. BCA-endotypes were identified and survival rates were compared between BCA-derived patient clusters. Patients with high-risk cytogenetics exhibited elevated cardiac marker index values. Across Revised-International Staging System (R-ISS) categories, BCA parameters did not show significant differences. However, both subcutaneous and total adipose tissue volumes were significantly lower in patients with progressive disease or death during follow-up compared to patients without progression. Cluster analysis revealed two distinct BCA-endotypes, with one group displaying significantly better survival. Furthermore, a combined model composed of clinical parameters and BCA data demonstrated a higher predictive capability for disease progression compared to models based solely on high-risk cytogenetics or R-ISS. These findings underscore the potential of BCA to improve patient stratification and refining prognostic models in MM.